In this episode of ‘What’s New Doc’ in GU cancer, Prof Emmanuel Seront...
In metastatic renal cell cancer (mRCC), immune checkpoint inhibitors (ICI) are...
Professor Emmanuel Seront, medical oncologist at Cliniques Universitaires...
In this episode, Dr Nieves Martinez-Chanza from the Institut Jules Bordet in...
The regimen which combines lenvatinib with pembrolizumab, has become...
Prof Emmanual Seront, medical oncologist at Cliniques Universitaires Saint-Luc,...
In the primary analysis of the CLEAR study, the combination of lenvatinib and...